Merial Limited

Novartis Ag

Cornell University

Novartis Tiergesundheit Ag

Nikolaus Osterrieder

Jean-Christophe Francis Audonnet

Jules Maarten Minke

Jean Christophe Audonnet

Guanggang Ma

Richard Harland

Benedikt B Kaufer

Gopinath Raju Seetharaman

Lee David Albee, Ii

Mayur Navnitbhai Patel

Lee David Albee

The present invention provides compositions or vaccines that contain a recombinant EHV-1 that elicit an immune response in animals against equine herpesvirus, including compositions comprising the recombinant EHV-1, methods of vaccination against equine herpesvirus, and kits for use with such methods and compositions.

Recombinant equine herpesvirus-1 vaccine containing mutated glycoprotein C and uses thereof

The present invention provides compositions or vaccines that contain a recombinant EHV-1 that elicit an immune response in animals against equine herpesvirus, including compositions comprising said recombinant EHV-1, methods of vaccination against equine herpesvirus, and kits for use with such methods and compositions.

The disclosure relates generally to the treatment or prevention of disease in cattle. More particularly, the invention is directed to the production and use of modified bovine herpesvirus 1 (BHV-1) and their use in compositions and vaccines that protect cattle from BHV-1 infection while not suppressing the immunological response in the host. In one example, the invention is directed to the use of modified BHV-1, administered with additional immunogens, either through co-administration and/or through administration in combination vaccines, and the use of these vaccines for the protection of cattle from disease. In one example, use of the modified BHV-1 in the administered compositions facilitates an immune response to or against the additional immunogens.

Bovine herpes virus-1 compositions, vaccines and methods

Growing community of inventors

Potsdam, Germany

Nikolaus Osterrieder